A lot of news today with the ASCO Abstracts being released. I will leave the interpretation of the abstracts to people that are much more qualified to discuss them than I:
- After nerve-wracking eye surgery, the world comes into focus for early gene therapy recipient.
- The top winners and losers on ASCO abstract night: Loxo, Blueprint, Jounce, Merck KGaA and more
- Biopharma, Regulators and Researchers Turn Their Focus to Universal Flu Vaccines
- Former Novartis CEO Explains Why His Company Paid Trump Lawyer Michael Cohen $1.2 Million
Have a great day!
MattCorc 